Home » Topics » BioWorld Science

BioWorld Science
RSS

Genzyme and NCI sign CRADA for melanoma gene therapy

Oct. 25, 1996

Aviron-NeuroVir gene therapy alliance

Oct. 25, 1996

Selective killing of p53-deficient human tumor cells with mutant adenovirus

Oct. 25, 1996

NIH seeks to license invention related to compounds inducing apoptosis

Oct. 25, 1996

Japanese researchers disclose anticancer applications of the E1AF gene

Oct. 25, 1996

NIH seeks licensees for novel laminin molecule that lacks affinity for collagen IV

Oct. 25, 1996

GV-1301 and GV-1302 available for licensing

Oct. 25, 1996

Follow-up confirms safety of PN-27.1

Oct. 25, 1996

New antitumor agent from Banyu

Oct. 25, 1996

CRC Technology reports antitumor activity of DF-203

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...